Skip to main content

Correction: Bone marrow mesenchymal stem cells combined with estrogen synergistically promote endometrial regeneration and reverse EMT via Wnt/β-catenin signaling pathway

The Original Article was published on 15 August 2022

Correction: Reprod Biol Endocrinol 20, 121 (2022)

https://doi.org/10.1186/s12958-022-00988-1

Following publication of the original article [1], the authors identified an error in Figs. 3 and 4. The correct figures are given below.

Fig. 3
figure 1

Quantitative assessment of BMSCs transplantation time. A (a): The normal uterine morphology of a rabbit; (b): Morphology of rabbit uterus after mechanical and infectious double injury; (c): Morphology after one week of injury). B Western blot was used to detect the protein expression of fibrosis markers (N-cadherin, Collagen I, TGF-β1, α-SMA) at different time points. *p < 0.05. The explanation for the cropping of gels and blots in the experiment is as follows: the same proteins were separated by electrophoresis and transferred to PVDF membrane. According to the different molecular weight of the target antibody, the protein on a PVDF membrane was cropped horizontally. Then, the corresponding antibody was incubated and exposed, and the position of antibody was indicated by protein marker to ensure the exclusion of interference from non-specific antibody magazines

Fig. 4
figure 2

Evaluation of the effect of BMSCs combined with estrogen on endometrial morphological recovery. A HE staining was performed to detect the endometrial glands in each group at different time points (× 100, scale bar = 100 μm). B Masson staining was performed to detect intrauterine fibrosis changes in each group at different time points (× 100, scale bar = 100 μm). C Statistical results of changes in the number of endometrial glands. D Statistical results of intrauterine fibrosis changes after endometrial damage. *p < 0.05, **p < 0.01, ***p < 0.001

The original article [1] has been updated.

Reference

  1. Yuan L, Cao J, Hu M, et al. Bone marrow mesenchymal stem cells combined with estrogen synergistically promote endometrial regeneration and reverse EMT via Wnt/β-catenin signaling pathway. Reprod Biol Endocrinol. 2022;20:121. https://doi.org/10.1186/s12958-022-00988-1.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dan Liu.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yuan, L., Cao, J., Hu, M. et al. Correction: Bone marrow mesenchymal stem cells combined with estrogen synergistically promote endometrial regeneration and reverse EMT via Wnt/β-catenin signaling pathway. Reprod Biol Endocrinol 20, 172 (2022). https://doi.org/10.1186/s12958-022-01047-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12958-022-01047-5